We have investigated the interaction of human cytomegalovirus (CMV) with cultured primary granulo- 
CD15+, CD33+ cell surface phenotype during propagation in suspension culture. Exposure to human CMV did not reduce growth or alter the phenotype of these cells during a 4-week culture period. Viral replication was not detectable in these celis, although viral DNA, as measure by PCR analysis, persisted in a high proportion of cultured cells in the absence of delayed early (I) gene expression. Viral gene expression was restricted such that only ki region transcripts were detected by PCR analysis of cDNA, and these transcripts were t Aed to be present in no less than 2-5% of latently infected cells. Most of these transcripts remained unspliced, a result that strikingly contrasts with the splicing pattern normally seen during viral replication in permissive cells. Latent virus reactivated after prolonged, 16-to 21 -day cocultivation of infected granulocytemacrophage progenitors with permissive cells, results that support a role for the myelomonocytic cell population as a biological reservoir of latent human CMV and suggest that these cells may be the source of CMV DNA PCR-positive monocytes found in the peripheral blood of healthy carriers.
Human cytomegalovirus (CMV), a ubiquitous speciesspecific herpesvirus and significant pathogen in immunocompromised individuals and neonates (1) , is the best studied member of the betaherpesviruses (2) . Although latent infection by CMV is widespread and reactivation of latent virus after either immunosuppression or progressive immunodeficiency is the single most important contributor to emergence of CMV disease, the site(s) of viral latency remain poorly characterized. Viral DNA has been detected in peripheral blood cells of healthy seropositive carriers (3, 4) , and monocytes have been implicated as the most likely cell type harboring latent viral genomes (4) . Although the CMV genome persists in monocytes, virus does not reactivate during cultivation under conditions that stimulate growth and differentiation (5) . Thus, it has remained unclear whether monocytes, or other mononuclear cell types in peripheral blood, correspond to true sites of latency or reflect an occasional depository of viral DNA during sporadic reactivation (6) (7) (8) .
A wide range of peripheral blood leukocytes has been shown to restrict CMV replication after infection (6, 7, (9) (10) (11) . Monocytes and bone marrow-derived granulocyte-macrophage progenitors (GM-Ps) have been the focus of many experiments. These fail to support viral replication, but reports on viral gene expression have been inconsistent (10, (12) (13) (14) (15) . These investigations have suggested a role for GM-Ps as a reservoir of persistent or latent CMV infection.
MATERIALS AND METHODS Cell and Virus Culture. Fetal liver cells (from 12-to 18-week abortuses) were cultured in Iscove's modified Dulbecco's medium (GIBCO/BRL) supplemented with 5% fetal bovine serum, 5% conditioned medium from the 5637 bladder carcinoma cell (ATCC HTB9), penicillin G (100 units/ml), and streptomycin (100 pg/ml) (16 (19) . Infected GM-Ps were introduced into HF cell cultures to recover virus by cocultivation.
Nested DNA PCR and Cell Diution. Cells or nuclei were counted and diluted to give an average of 100, 30, 10, 3, and 1 per tube, and DNA was extracted as described (20) . Nuclei were prepared from cells lysed on ice in 20 mM Hepes-KOH, pH 7.9/5 mM KCl/0.5 mM MgCl2/5 mM dithiothreitol/0.1% Triton X-100 and were monitored by phase-contrast microscopy. Initial PCR amplification was with iel primers IEP4BII and IEP2AII (Table 2) (25) . Previous studies had shown that CMV replicates in human medullary thymic epithelium (26) and human bone marrow stromal cells (H.K., E.S.M., and M. Bonyhadi, unpublished work). Using bone marrow cells from infected implants, colony forming units of granulocyte-macrophage (CFU-GM) cells were identified by methylcellulose colony-forming assay (25) . CMV DNA was detected in pools of -100 colonies, although virus was not recovered from cells after either freeze-thaw lysis or 12-day coculture with permissive HF cells. This work suggested that CMV may gain entry into GM-Ps and remain latent.
To establish cultures in which the direct interaction of CMV with GM-Ps could be investigated, fetal bone marrow or liver cells were cultivated under myelomonocytic cell culture conditions (16 (Fig. 1) . More than 50%o of the cells used to initiate these cultures were CD33+, and a small proportion were CD34+ and capable of forming CFU-GM. After 2 weeks in culture, CFU-GM were no longer detectable by methylcellulose colony-forming assay, probably due to the loss, through differentiation, of the precursor population. Also, neither CD34+ nor CD19+ (B-cell lineage) cells were detectable when suspension cultures were evaluated 2 weeks after being established.
For infection with CMV, duplicate or triplicate samples of 106 fetal liver cells from 10 individual CMV-negative sources were cultured. Three days later, nonadherent cells were collected, counted, and exposed to CMV (strain RC256) at a multiplicity of infection of 3. We used RC256, a derivative of the Towne strain that carries the lacZ gene under control of the strong CMV 13 (delayed early) promoter (12.7), because this virus expresses abundant levels of P3-galactosidase (EGal), which provided a simple sensitive indicator of viral replication in cells or tissues (17, 26 Fig. 2B ). The number of GM-Ps per culture was determined by direct counting, and the number of DNA-positive infected cells was determined by celldilution PCR studies (Table 1 and Fig. 2A ). (Inset) Morphology of nonadherent GM-Ps. r, Starting cell number; *, CFU-GM; *, infected cell number; o, total cell number; *, DNA copy number. Ten samples of RC256-infected GM-P cells were harvested at 3 or 4 weeks postinfection (PI). Freeze/thaw (F/T)-released free virus was plaque-assayed on HF cells. GM-Ps (105) were cocultivated with HF cells for 12 days to detect infectious centers (C). (-Gal was detected by overlay of 105 cells with 5-bromo-3-chloro-indolyl P-Dgalactoside (X-gal) as described (17) . DNA isolated from the indicated numbers of cells was extracted and subjected to nested PCR assay using iel region primers and conditions described in Fig. 2A tNumber of cells assayed.
Despite the absence of infectious virus and (3-Gal expression, a high proportion (between 10%6 and 100%6, depending on the sample) of infected GM-Ps from 10 different tissue samples were positive for CMV DNA by cell-dilution PCR analysis (Table 1 ) with a nested set of primers for iel region ( Table 2 ). The interaction ofCMV with GM-Ps is summarized in Fig. 1 Fig. 2A . Results of this analysis for all samples showed that CMV DNA was present in between 10%o and 100%6 of GM-Ps (Table 1) . Quantitative competitive PCR (27) with an iel cDNA clone as competitor was used to estimate a viral genome copy number of 10-100 copies per genome-positive cell. This range was also observed when nuclear DNA was analyzed (an example is shown in Fig. 2B ). Thus, CMV DNA was quantitatively associated with GM-P cells at genome copy numbers characteristic of latent infection by other herpesviruses.
The results suggested that the CMV genome was maintained in GM-Ps in the absence ofproductive viral replication. When cells were maintained in the presence of ganciclovir at concentrations of this drug known to inhibit productive viral replication (5 or 10 MuM), GM-P cell number increased 3-to 10-fold over a period of 2 weeks, and viral genome copy (20) . Position ofthe 167-bp product generatedby nested PCR with iel-specific primers, first using IEP4BII and IEP2AII (Table 2) for 30 cycles and then using IEP3B and IEP3A for 30 cycles, is indicated next to the lanes of ethidium bromide-stained agarose gel. (B) CMV DNA copy number. DNA isolated from 1.3 x 104 cells (at left) or 1.3 x 104 nuclei (at right) was subjected to quantitative PCR with primers 1PE3C and IEP4BII (Table 2 ) in the presence of 3 x 103 to 1 x 106 copies of a denatured human CMV iel cDNA plasmid as competitor; copy numbers are indicated above lanes. Arrows, position of 387-bp product from human CMV DNA and 217-bp product from the competitive template. Results reveal that -3 x 104 CMV genomes were present in these samples, equivalent to '20 genomes per genome-positive cell. MWM, 100-bp ladder (GIBCO/BRL). increased proportionately (data not shown). No differences in morphology or cell growth characteristics were seen in infected cultures when compared with uninfected controls, and a low-passage strain of virus, Toledo strain (18), gave similar results to those described for the Towne strain derivative RC256. An additional 19 individual samples of fetal liver and three samples of fetal bone marrow cells were tested in this system using either strain of virus, and results consistent with those described here were obtained. We noticed that the GM-Ps continued to proliferate during the 12 days of coculture with HF cells, despite the fact that they had already been in myelomonocytic culture for as long as a month. Therefore, we investigated whether virus might be recovered after a longer period of cocultivation. GM-Ps from 10 individual sources were harvested at 4 weeks after infection and seeded at 300 cells per well together with HF cells. These cultures were maintained for an additional 3-week period. Recovery of virus (plaque formation) was (Table  3) . Although the GM-Ps remained virus-negative through the 12-day time point, by 21 days, 80%o of samples yielded virus. For comparison, a few productively infected HF cells cultured in parallel yielded plaques within 5 days (Table 3) , and an input of one cell-free infectious virus yielded a plaque within 7 days (data not shown). Thus, virus associated with GM-Ps is recovered with considerably delayed kinetics, consistent with reactivation from latency rather than persistence of small amounts of infectious virus. Reactivation occurred in all of the 10 samples studied when 300 GM-Ps were seeded, thereby showing reproducible recovery of infectious virus from the latently infected GM-Ps. When fewer than 300 GM-Ps were seeded, proportionately fewer wells showed reactivation, suggesting that every genomepositive cell in the culture was not capable of yielding virus under these conditions. Similar results were obtained with the low-passage Toledo strain of CMV (data not shown).
We surveyed 10 different latently infected GM-P cultures for evidence of viral f3 gene expression by direct RT-PCR. Fig. 3 A and B show examples of RT-PCR analyses from five different samples of RNA from 105 cells using PCR primers capable of detecting unspliced transcripts from the abundantly expressed 32.7 gene (28) and from a family of spliced transcripts from the UL112-113 gene (29) . Neither of these transcripts was detected, even though the conditions were sensitive enough to detect transcripts in a single infected HF cell (8 hr after infection) mixed in with 105 uninfected GM-Ps.
Transcription from a region of the a gene, iel, was readily detected in all six latently infected GM-P cultures, even when Table 2 . PCR products are denoted by an arrow next to the panels.
RNA from as few as 103 cells was evaluated by RT-PCR (three examples are shown for each of two different iel splice junctions in Fig. 3 C and D) . Analyses using RNA from uninfected GM-Ps were uniformly negative. Surprisingly, the signal we observed was largely derived from unspliced RNA in the infected GM-Ps, rather than from spliced RNA typical of either productively infected HF or abortively infected mouse NIH 3T3 fibroblasts. An overwhelming majority of iel region RNA remained unspliced in all six independent GM-P cultures examined and was readily detected in RNA from 103 cells by RT-PCR. The presence of unspliced RNA was demonstrated between exons 2 and 3 (Fig. 3C ) or between exons 3 and 4 ( Fig. 3D) (3, 4) , the absence of a manipulable system to reactivate virus has limited any understanding of these cells as sites of latent infection. Our work establishes a system to study CMV persistence in human bone marrow-derived primary myelomonocytic cells, a potential reservoir of latent CMV in healthy carriers (4) . The system described here opens the way to investigate the establishment, maintenance, and reactivation phases of latent infection.
We have found that CMV infection of GM-Ps is noncytocidal and that viral gene expression is restricted. Previous studies have suggested that the GM-P population restricts CMV replication, although stromal cells support CMV replication (12) (13) (14) (15) . Interestingly, CMV gene expression was similarly restricted in the large adherent cells that develop in these cultures. We identified an atypical, unspliced iel region transcript in infected GM-Ps, and the expression of this transcript can now be evaluated directly as a marker of latency in healthy carriers.
The ability to activate virus after extended cocultivation with permissive cells indicates that CMV replication in GM-Ps depends upon growth or differentiation that occurs during cocultivation. The dependence of CMV replication on the differentiation state of cells-in particular, monocytes (5-7)-has been the topic ofstudy in several laboratories. We can now investigate the importance of viral and host cell functions in latent infection using the GM-P cell culture system. Our study establishes that both low-passage as well as high-passage laboratory strains of CMV retain the biological potential for latent infection of GM-Ps. During latent infection viral DNA is stably associated with growing cells, and a ganciclovir-resistant parallel increase in viral DNA along with cell number occurs during culture. Our results suggest a mechanism for maintaining the viral genome in latently infected GM-Ps that is distinct from that used during productive replication. The detection of atypical iel region transcripts suggests that the products may play some role in latent infection, possibly in genome maintenance. In addition to yielding information on the nature of the viral genome and viral gene expression, this system will enable the direct investigation of the role of atypical transcripts from the iel region in establishment or maintenance of latent infection.
